The ventilation/perfusion mismatch in chronic obstructive pulmonary disease (COPD) patients can exacerbate cardiac function as well as pulmonary oxygenation. We hypothesized that inhaled iloprost can ameliorate pulmonary oxygenation with lung mechanics and myocardial function during one-lung ventilation (OLV) in COPD patients combined with poor lung oxygenation.
A total of 40 patients with moderate to severe COPD, who exhibited the ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen (Pao2/Fio2) <150 mm Hg 30 minutes after initiating OLV, were enrolled in this study. Patients were randomly allocated into either ILO group (n = 20) or Control group (n = 20), in which iloprost (20 μg) and saline were inhaled, respectively. The Pao2/Fio2 ratio, dead space, dynamic compliance, and tissue Doppler imaging with myocardial performance index (MPI) were assessed 30 minutes after initiating OLV (pre-Tx) and 30 minutes after completion of drug inhalation (post-Tx). Repeated variables were analyzed using a linear mixed-model between the groups.
At pre-Tx, no differences were observed in measured parameters between the groups. At post-Tx, Pao2/Fio2 ratio (P < .001) and dynamic compliance (P = .023) were significantly higher and dead space ventilation was significantly lower (P = .001) in iloprost group (ILO group) compared to Control group. Left (P = .003) and right ventricular MPIs (P < .001) significantly decreased in ILO group compared to Control group.
Inhaled iloprost improved pulmonary oxygenation, lung mechanics, and cardiac function simultaneously during OLV in COPD patients with poor lung oxygenation.
- Question: What is the impact of iloprost inhalation on lung mechanics and myocardial function during one-lung ventilation (OLV) in chronic obstructive pulmonary disease (COPD) patients combined with poor lung oxygenation?
- Findings: Partial pressure of arterial oxygen to the fraction of inspired oxygen (Pao2/Fio2) ratio, lung mechanics, and biventricular function were improved by 20 µg of iloprost inhalation in patients who exhibited Pao2/Fio2 ratio <150 mm Hg during OLV.
- Meaning: We demonstrated that inhaled iloprost had a positive cardiopulmonary effect during OLV in patients with COPD combined with poor lung oxygenation.